Original Source(s)
Related Content
Vamikibart Shows Early Safety in Uveitic Macular Edema
Phase 1 nonrandomized trial reported no drug-related serious adverse events, but efficacy remains unproven
by Kerri Miller
May 7, 2026
-
3 min
What RVO May Reveal About Systemic Health
TriNetX data presented at Retina World Congress linked BRVO and CRVO with increased risks of stroke, myocardial infarction, and carotid disease.
May 14, 2026
-
3 min